ProCE Banner Activity

Case Discussion: Overview of the Current Treatment Landscape for mCRPC

Slideset Download
Download these slides from a live symposium to learn more about the current treatment landscape in mCRPC

Released: February 18, 2022

Expiration: February 17, 2023

No longer available for credit.

Share

Faculty

Matthew R. Smith

Matthew R. Smith, MD, PhD

Professor of Medicine
Harvard Medical School
Director
Genitourinary Malignancies Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Novartis Pharmaceuticals Corp Advanced Accelerator Applications

Sanofi Genzyme

Program Director Disclosure

Program Director

Matthew R. Smith, MD, PhD

Professor of Medicine
Harvard Medical School
Director
Genitourinary Malignancies Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Matthew R. Smith, MD, PhD, has disclosed that he has received consultant/advisor/speaker fees from Amgen, Astellas, Bayer, Janssen, Lilly, and Pfizer.